Investor Brief

Crown MycoResin Biotech Inc. is a biotechnology company developing proprietary myco-resin induction and fungal–plant interaction technologies designed to enhance resin formation, secondary metabolite expression, and value realization in high‑value aromatic and perfumery crops, led by agarwood (Aquilaria spp.). The company bridges laboratory science with commercial plantations through its MycoResin™ and Lab‑to‑Land™ platforms, enabling predictable yields, quality consistency, and scalable deployment aligned with ESG principles.

Problem

Traditional resin and aromatic crop production faces:

  • Unpredictable resin formation and quality variability
  • Long biological timelines and uncertain ROI
  • Environmental pressure and unsustainable induction practices
  • Fragmented value chains with limited traceability

Our Solution

MycoResin™ Technology Platform integrates:

  • Beneficial fungal systems and controlled stress signaling
  • Resin and metabolite pathway activation
  • Species‑specific SOPs and plantation protocols
  • Lab‑validated methods deployed in real farm environments

This results in higher resin probability, improved quality profiles, and accelerated value capture.

Technology & IP

  • Proprietary fungal consortia and induction protocols
  • Species‑specific application for agarwood and aromatic crops
  • Lab‑to‑Land™ deployment manuals and training systems
  • Ongoing IP development, documentation, and protection

Products & Applications

  • MycoResin™ induction protocols (B2B / licensing)
  • Plantation integration & technical services
  • Resin‑grade raw materials
  • Downstream extracts and fragrance inputs (via partners)

Market Opportunity

  • Global oud and natural fragrance markets
  • Wellness, aromatherapy, and bio‑based ingredients
  • High‑value agroforestry and sustainable land investments

Positioned at the intersection of biotechnology, agroforestry, and luxury natural products.

Business Model

  • Technology licensing & service fees
  • Joint ventures with plantation owners
  • Equity participation in pilot and commercial sites
  • Revenue sharing across vertically integrated value chains

Traction & Readiness

  • Protocol development and validation underway
  • Alignment with agroforestry and extraction partners
  • Pilot plantation integration roadmap
  • Investor‑ready scale‑up plan

ESG & Impact

  • Sustainable resin induction alternatives
  • Reduced ecological stress and tree mortality
  • Rural livelihood and farmer capacity building
  • Traceable, ethical, and compliant production systems

Investment Use of Funds

  • R&D scale‑up and protocol refinement
  • Pilot and commercial deployment
  • IP protection and documentation
  • Talent, lab, and field operations

Ideal Investors

  • Agri‑biotech & life sciences investors
  • Fragrance, perfumery, and wellness partners
  • Impact & ESG funds
  • Family offices seeking long‑term biological assets

Strategic Vision

To become a leading myco‑biotechnology platform for high‑value resin and aromatic crops across Southeast Asia and global perfumery markets.